Insider · CIK 0001959750

Arif Bilal

Reports to the SEC for 2 companies · FRAMINGHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001959750

Forms 4 and 5

Insider transactions

46 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-11	KalVista Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Operations Officer	DDisposition to Issuer	−100K sh	—	—	0
2026-06-11	KalVista Pharmaceuticals, Inc.Restricted Stock UnitD Disposition to Issuer	Chief Operations Officer	DDisposition to Issuer	−49K sh	—	—	0
2026-01-16	KalVista Pharmaceuticals, Inc.Restricted Stock UnitA Award	Chief Operations Officer	AAward	+49K sh	—	—	49,000
2025-10-08	KalVista Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Chief Operations Officer	AAward	+100K sh	—	—	100,000
2025-08-05	SRPTSarepta Therapeutics, Inc. · Performance Stock UnitsA Award	Chief Tech Ops Officer	AAward	+6,250 sh	—	—	6,250
2025-03-10	SRPTSarepta Therapeutics, Inc.F Tax Payment	Chief Tech Ops Officer	FTax Payment	−523 sh	$100.13	−$52.4K	24,224
2025-03-10	SRPTSarepta Therapeutics, Inc. · Stock Options (right to buy)A Award	Chief Tech Ops Officer	AAward	+16.6K sh	—	—	16,644
2025-03-10	SRPTSarepta Therapeutics, Inc.A Award	Chief Tech Ops Officer	AAward	+8,276 sh	—	—	32,500
2025-03-07	SRPTSarepta Therapeutics, Inc.F Tax Payment	Chief Tech Ops Officer	FTax Payment	−8,527 sh	$103.70	−$884K	24,747
2025-03-07	SRPTSarepta Therapeutics, Inc.F Tax Payment	Chief Tech Ops Officer	FTax Payment	−508 sh	$103.70	−$52.7K	33,274
2025-03-06	SRPTSarepta Therapeutics, Inc. · Performance Stock UnitsM Exercise/Conversion	Chief Tech Ops Officer	MExercise/Conversion	−17.5K sh	—	—	0
2025-03-06	SRPTSarepta Therapeutics, Inc.M Exercise/Conversion	Chief Tech Ops Officer	MExercise/Conversion	+17.5K sh	—	—	33,782
2025-03-04	SRPTSarepta Therapeutics, Inc.F Tax Payment	Chief Tech Ops Officer	FTax Payment	−281 sh	$101.34	−$28.5K	16,515
2025-03-04	SRPTSarepta Therapeutics, Inc.F Tax Payment	Chief Tech Ops Officer	FTax Payment	−233 sh	$101.34	−$23.6K	16,282
2025-03-03	SRPTSarepta Therapeutics, Inc.F Tax Payment	Chief Tech Ops Officer	FTax Payment	−719 sh	$103.77	−$74.6K	16,796
2025-02-11	SRPTSarepta Therapeutics, Inc. · Performance Restricted Stock UnitsA Award	Chief Tech Ops Officer	AAward	+3,500 sh	—	—	17,500
2024-06-25	SRPTSarepta Therapeutics, Inc.S Sale	Chief Tech Ops Officer	SSale	−3,898 sh	$163.23	−$636K	17,363
2024-06-24	SRPTSarepta Therapeutics, Inc.S Sale	Chief Tech Ops Officer	SSale	−700 sh	$166.10	−$116K	21,485
2024-06-24	SRPTSarepta Therapeutics, Inc.S Sale	Chief Tech Ops Officer	SSale	−300 sh	$164.61	−$49.4K	22,185
2024-06-24	SRPTSarepta Therapeutics, Inc.S Sale	Chief Tech Ops Officer	SSale	−224 sh	$167.13	−$37.4K	21,261
2024-06-24	SRPTSarepta Therapeutics, Inc.S Sale	Chief Tech Ops Officer	SSale	−1,055 sh	$163.83	−$173K	22,485
2024-06-24	SRPTSarepta Therapeutics, Inc.S Sale	Chief Tech Ops Officer	SSale	−5,580 sh	$162.31	−$906K	23,540
2024-06-24	SRPTSarepta Therapeutics, Inc.F Tax Payment	Chief Tech Ops Officer	FTax Payment	−2,352 sh	$164.64	−$387K	29,120
2024-06-21	SRPTSarepta Therapeutics, Inc. · Performance Stock UnitsA Award	Chief Tech Ops Officer	AAward	+6,250 sh	—	—	6,250
2024-06-21	SRPTSarepta Therapeutics, Inc.M Exercise/Conversion	Chief Tech Ops Officer	MExercise/Conversion	+6,250 sh	—	—	31,472
2024-06-21	SRPTSarepta Therapeutics, Inc. · Performance Stock UnitsM Exercise/Conversion	Chief Tech Ops Officer	MExercise/Conversion	−6,250 sh	—	—	0
2024-03-08	SRPTSarepta Therapeutics, Inc.F Tax Payment	Chief Tech Ops Officer	FTax Payment	−472 sh	$123.14	−$58.1K	25,222
2024-03-07	SRPTSarepta Therapeutics, Inc.F Tax Payment	Chief Tech Ops Officer	FTax Payment	−506 sh	$120.49	−$61K	25,694
2024-03-04	SRPTSarepta Therapeutics, Inc.F Tax Payment	Chief Tech Ops Officer	FTax Payment	−237 sh	$125.32	−$29.7K	26,200
2024-03-04	SRPTSarepta Therapeutics, Inc.F Tax Payment	Chief Tech Ops Officer	FTax Payment	−285 sh	$125.32	−$35.7K	26,437
2024-03-01	SRPTSarepta Therapeutics, Inc.S Sale	Chief Tech Ops Officer	SSale	−1,543 sh	$128.58	−$198K	27,293
2024-03-01	SRPTSarepta Therapeutics, Inc.F Tax Payment	Chief Tech Ops Officer	FTax Payment	−251 sh	$126.19	−$31.7K	22,836
2024-03-01	SRPTSarepta Therapeutics, Inc.A Award	Chief Tech Ops Officer	AAward	+6,000 sh	—	—	28,836
2024-03-01	SRPTSarepta Therapeutics, Inc.S Sale	Chief Tech Ops Officer	SSale	−457 sh	$129.71	−$59.3K	26,836
2024-03-01	SRPTSarepta Therapeutics, Inc.F Tax Payment	Chief Tech Ops Officer	FTax Payment	−114 sh	$126.19	−$14.4K	26,722
2024-03-01	SRPTSarepta Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Tech Ops Officer	AAward	−12.5K sh	—	—	12,500
2023-12-01	SRPTSarepta Therapeutics, Inc.F Tax Payment	Chief Tech Ops Officer	FTax Payment	−3,682 sh	$80.34	−$296K	22,886
2023-03-30	SRPTSarepta Therapeutics, Inc.F Tax Payment	Chief Tech Ops Officer	FTax Payment	−307 sh	$136.66	−$42K	26,367
2023-03-08	SRPTSarepta Therapeutics, Inc.F Tax Payment	Chief Tech Ops Officer	FTax Payment	−314 sh	$153.19	−$48.1K	26,674
2023-03-06	SRPTSarepta Therapeutics, Inc.F Tax Payment	Chief Tech Ops Officer	FTax Payment	−154 sh	$157.21	−$24.2K	22,488
2023-03-06	SRPTSarepta Therapeutics, Inc.F Tax Payment	Chief Tech Ops Officer	FTax Payment	−186 sh	$157.21	−$29.2K	22,642
2023-03-06	SRPTSarepta Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Tech Ops Officer	AAward	+27K sh	—	—	27,000
2023-03-06	SRPTSarepta Therapeutics, Inc.A Award	Chief Tech Ops Officer	AAward	+4,500 sh	—	—	26,988
2023-03-01	SRPTSarepta Therapeutics, Inc.F Tax Payment	Chief Tech Ops Officer	FTax Payment	−80 sh	$147.57	−$11.8K	22,837
2023-03-01	SRPTSarepta Therapeutics, Inc.F Tax Payment	Chief Tech Ops Officer	FTax Payment	−172 sh	$147.57	−$25.4K	22,828
2022-12-31	SRPTSarepta Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Tech Ops Officer	AAward	+30K sh	—	—	30,000

Recent filings

Accepted (ET)
Jun 114
Arif Bilal0001959750-26-000003
SEC(opens sec.gov)
Jan 214
Arif Bilal0001959750-26-000001
SEC(opens sec.gov)
Oct 84
Arif Bilal0001959750-25-000006
SEC(opens sec.gov)
Aug 64
Arif Bilal0000950170-25-104399
SEC(opens sec.gov)
Mar 114
Arif Bilal0000950170-25-037524
SEC(opens sec.gov)
Mar 104
Arif Bilal0000950170-25-036691
SEC(opens sec.gov)
Mar 64
Arif Bilal0000950170-25-035005
SEC(opens sec.gov)
Mar 44
Arif Bilal0000950170-25-032761
SEC(opens sec.gov)
Feb 134
Arif Bilal0000950170-25-020191
SEC(opens sec.gov)
Jun 254
Arif Bilal0000950170-24-077518
SEC(opens sec.gov)

Companies

Address

C/O KALVISTA PHARMACEUTICALS, INC. 200 CROSSING BOULEVARD

FRAMINGHAM, MA, 01702